Italia markets closed

Almirall, S.A. (0O9B.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
10,34-0,14 (-1,34%)
Alla chiusura: 05:53PM BST
Schermo intero
Chiusura precedente10,48
Aperto10,43
DenaroN/D x N/D
LetteraN/D x N/D
Min-Max giorno10,36 - 10,57
Intervallo di 52 settimane10,36 - 10,57
Volume27.577
Media VolumeN/D
Capitalizzazione18,143M
Beta (5 anni mensile)0,52
Rapporto PE (ttm)N/D
EPS (ttm)-0,28
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Athenex Announces Phased European Launch of Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis

    Klisyri has been approved for the treatment of actinic keratosis by the UK Medicines and Healthcare products Regulatory Agency and will initially be available for prescription in the UK and Germany AK is one of the most common diagnoses made by dermatologists in Europe and Almirall plans to a phased roll-out for other European countries BUFFALO, N.Y., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and